Levamisole |
|
| Description | Levamisole has been used in humans to treat parasitic worm infections, and has been studied in combination with other forms of chemotherapy for colon cancer, melanoma, and head and neck cancer. The drug was withdrawn from the U.S. and Canadian markets in 2000 and 2003 respectively, due to the risk of serious side effects. |
| Therapeutic Low | 0.0000 |
| Therapeutic High | 0.0000 |
| Units | ug/mL |
| Specimen | P |
| Half Life Low | 0.00 |
| Half Life High | 0.00 |
| VOD Low | 0.00 |
| VOD High | 0.00 |
| Toxic Level | 0.000 |
| Lethal Level | 0.000 |
| Plasma to Whole Blood ratio | 0.00 |
| Warnings | |